SyntekaBio Inc. - AI drug development service

STB Cloud for Global Health Syntekabio's DeepMatcher fuels the engine at ABS Center, where disease barriers crumble and 100+ molecules at a time unlock new cures for a healthier future. Witness the power of AI-powered, disease-agnostic research in action with us! #AIDrugDiscovery

@SyntekaBio is excited to be attending BioInternational Convention in June. Let us know if you'll be attending! #aidrugdiscovery #biotechnology #pharmaceuticals

Syntekabio to Showcase Biologics Discovery Platform at PEGS Boston next week! tinyurl.com/238phhtk #AI #AIdrugdiscovery #Antibodydrug

@Syntekabio will be showcasing our AI-based technology for NeoAntigenPrediction and Antibody Drug Discovery at the @PEGSummit in Boston, May 13-17, 2024. Stop by our Booth #40 to learn more. See you there! #PEGSummit #AI #BiologicDiscovery #AntibodyDrug #GeneTherapy

@SyntekaBio to Showcase Innovative AI Drug Discovery Technologies at Bio-IT World: Don’t make patients wait – offering solutions to rapidly bring novel drugs to IND-enabling stage globenewswire.com/news-release/2…

What’s new in AI and supercomputing for drug discovery? @Syntekabio will be attending the @Bioitworld Conference in Boston, Apr 15-17 Learn more about our AI-based development of small molecule drugs for 100+ targets covering 60-70% of major diseases, at Booth #22 #AI

Welcome to the Drug Discovery World, ABS Center! #AIDrugDiscovery #DrugDiscovery #AI

We are going to open AI Bio Supercomputer Center in Daejeon with 10,000 units! A big leap in #AIDrugDiscovery, #Genomics, & #PersonalizedMedicine, driving progress in #GlobalHealth. Witness the future of #AI in #PharmaceuticalIndustry with @Syntekabio biz.onvi.co.kr/syntekabio_en.…

Sadjad, business development scientist at Syntekabio, is attending the #BioFuture2023 conference in New York City to promote our full-cycle #DeepMatcher drug candidate service. Wishing him all the best and success!

The #DeepMatcher service by @SyntekaBio is a pioneer in the #AI #drug_discovery field. DeepMatcher is equipped with modern deep learning techniques to fully optimize drug discovery and development.

🔬 Exciting news! Syntekabio launched the Deepmatcher Drug Candidate service aiming to revolutionize the drug discovery process by cutting timelines to a few years and reducing costs by many folds! 💊👩‍🔬 #DrugDiscovery #PersonalizedMedicine #CloudComputing cloud.syntekabio.com/platform

Unlocking AI-Driven Drug Discovery: Syntekabio's Supercomputing Approach biopharmatrend.com/post/674-synte… #biopharmatrend

The Power of STB CLOUD in Remote AI Drug Development biopharmatrend.com/post/664-the-p… #biopharmatrend

STB CLOUD, fully automated AI platform, designed for developers for easier and faster drug discovery. linkedin.com/pulse/stb-clou…

Hit Discovery Performance by DeepMatcher youtu.be/zkjjaIq8zxQ via @YouTube

Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung biopharmatrend.com/post/625-democ… #biopharmatrend

NYHF Webinar starts today 1/31/22 at 11:00AM, "2023 Trends in New Drug Development." Register now and join us from the link below. #biopharma #drugdevelopment #webinar newsdirect.com/news/2023-tren…

Participating Panelists. ~Hyun Joo, PhD | Principal Scientist/Director, @SyntekaBio ~Tae-Wan Kim, PhD | Associate Professor, @Columbia University ~Kern Chang, PhD | Scientific Integrator/Associate Director, @JanssenUS ~John Duguid, PhD | Managing Director, @auctusgroupinc

Syntekabio's Principal Scientist/Director Hyun Joo, Ph.D. is among the invited panelists at NYHF to discuss the "2023 Trends in New #DrugDevelopment", January 31, 2023, 11:00 AM – 12:00 PM. Register at the link below to attend the #webinar! nyhealthforum.net/specialwebinar3